Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Pathogenic bone loss in rheumatoid arthritis: mechanisms and therapeutic approaches
International Journal of Clinical Rheumatology, 10/19/09
Cantley MD et al. – The aim of this review is to demonstrate that antiresorptive therapies can prevent structural joint destruction, particularly in the early stages of anti–inflammatory treatment. A number of novel approaches targeting bone resorption are also becoming available.
Related Articles
Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: A 3-month, randomized, double-blind, placebo-controlled trial
Clinical Therapeutics, 10/15/09
Relevance Score: 71%
Certolizumab Pegol: In Rheumatoid Arthritis
BioDrugs, 11/11/09
Relevance Score: 70%
Assistive technology for rheumatoid arthritis
Cochrane Reviews, 10/09/09
Relevance Score: 70%
Treatment of early RA with infliximab is beneficial
American Pharmacists Association, 11/06/09
Relevance Score: 69%
Abatacept for rheumatoid arthritis
Cochrane Reviews, 10/09/09
Relevance Score: 69%
Today in Rheumatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Denuded subchondral bone and knee pain in persons with knee osteoarthritis
Arthritis & Rheumatism, 12/04/09
Long-term experience with etanercept in psoriatic arthritis patients: A 3-year observational study
Journal of Dermatological Treatment , 12/04/09
Are psychological treatments effective for fibromyalgia pain?
Current Rheumatology Reports, 12/04/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


